| Medical Cannabis therapeutics for Chinese Medicine Practitioners | Dr. Noelle Potash Dac. Lac, MSMCT |
| what is my cannabis use doing to my body from a TCM perspective? | |
| History | 10,000 year old clay jars filled with cannabis |
| 2500 year old mummy with breast cancer buried with cannabis |
| 2500 year old tombs containing cannabis |
| Scythians- nomadic people spread the knowledge of how to use cannabis throughout Asia. |
| Medicinal value | 2700 BCE -1900 ce, recognized as medicine throughout Asia |
| 2000 BCE- Ayurvedic, Persian, and Chinese medical physicians use for gout, epilepsy, pain, infectious disease. |
| 200 BCE-1900 Ce- used in Americas and Europe for pain, cough, tumors, 100 papers published. |
| 1914-2000 declared criminal activity. |
| Cultivation 4 subtypes of cannabis sativa | Narrow leaf-hemp (sativa) |
| Narrow leaf-drug (sativa) |
| Broad leaf-hemp (indica) |
| Broad leaf-drug (indica) |
| ID of different cultivars is based on leaflet size and now in modern times, Phyto cannabinoid ratios. |
| Classifying the plant into 2 or 3 types (Indica/sativa/ruderalis) does a disservice to the complexities of the plant and makes it really hard to predict therapeutic outcomes. |
| Cannabis use origins: China | Psychoactive type cannabis was found n northwest province of Xinjiang and the southwest province of Yunnan |
| Documented Chinese uses start over 2000 years ago with the first mention of medical uses in the Pen T’ao Ching in 2737 BCE. |
| the people of Guangxi provence continue to use cannabis in their daily food intake for “longevity”. |
| Many Names: | Ma Fen: Immature flower |
| Ma Fen is acrid, Balanced. Treats the 7 damages, disinhibits the five viscera, precipitates the blood and cold qi. |
| Taking to much of it may make one behold ghosts and run frenetically about. |
| Protracted (for a long time or longer than expected) taking may enable one to communicate with the spirit light and make the body light. |
| The seed is sweet and balanced. It mainly supplements the center and boosts qi. |
| Protracted taking may make one fat, strong, and never senile. |
| Ma Bo, the hemp spike, grows in rivers and valleys. (not/confuse with the Fructificatio Lasiosphaerae) |
| Mahua- mature cannabis flower. (not/confuse with the Madhuca longifolia) |
| Divine Farmers materia Medica | Mafen: It is toxic, breaks accumulations, relieves impediments and disperses pus. |
| The Great Encyclopedia of Chinese Medicinals | Mahua: dispels wind, relieves pain, settles tetany. |
| Indications: Bi syndrome, gout, withdrawal, Mania, insomnia, panting, and cough. |
| Yao Wu Tu Kao: illustrated analysis of medical substances. | Cannabis moves blood since it descends blood and cold qi. |
| Uses: headache, menstrual pain, irregularities, itching, convulsions, anemia, and dry cough. |
| Classical Combos (Dui Yao) | Mahua and Cao Wu for severe tetany, wind-bi syndrome. |
| Mafen, Shichang Pu, Gui Jiu (dysoma) for seeing ghosts. 100 days of a morning pill to see ghosts.- Li Shizhen |
| Mahua and Ren shen (ginseng): forgetfulness. “know the affairs of the world and the 4 directions”. Dementia, Foggy headedness, memory loss. Happiness in heart. |
| Classical formulations | Mafei powder: Hua tuo’s formula for sedation, analgesic, and surgery |
| Da ma Ren jiu: Mafen and Maziren preparation into wine. |
| Shui Sheng San: cannabis and daturia. Stupor or slumber for moxa on the skin. |
| Lu rong: aids cannabis. Young horn of deer. |
| Sun Sumiao: took the leaves and juiced them to add into a liniment for broken bones. |
| | “Eradicates hidden wind inside the body”. For hard to treat Wind-Bi syndrome. |
| Changes over time | 1995 to 2000: THC 4 to 8% TCH in cannabis |
| 2000 to 2015: 8 to 12% THC in cannabis |
| Chemotype I: THC > CBD |
| Chemotype II: THC = CBD |
| Chemotype III: THC < CBD |
| Endocannabinoid system | 1992 when researching effects of THC |
| The body’s homeostasis system, nervous system, immune system, brain and gut axis, affects everything. |
| More than receptors: enzymes, ligands (molecule or atom which binds to a protein like o2, dopamine, insulin), receptors to hormones and neurotransmitters |
| Endocannabinoidome: extends to our microbiome |
| Found in all vertebrates, throughout whole body. |
| Helps us to adapt to environment, stressors, hormones. |
| Endocannabinoids: 2 Main: | 2-arachidonoylglycerol (2-AG) |
| Arachidonoyl ethanolamine (AEA) |
| synthesized on demand. Metabolized by FAAH (AEA) and MAGL (2-AG) |
| 8 other lesser understood endocannabinoids | |
| Endocannabinoid receptors | CB1: in the CNS, brain and organs |
| CB2:in spleen, periphery, immune system, skeletal system |
| other receptors in the endocannabinoid system | GRP18, GRP119, GRP55 |
| other affected: | 5HT (serotonin), TRPV1, PPARa |
| Locations | CB1: brain, CNS, heart, lungs, digestive organs, skeletal, adipose tissue, blood vessels, eyes. |
| CB2: brain, periferial tissues, immune system, spleen, thymus |
| GRP18: brain, spine, skin, lymph, intestines, appendix, kidneys, lungs, reproductive organs, immune system. |
| GRP55: brain, intestines, lungs, pancreas, liver, urinary system, adrenals, adipose tissue, muscle, endothelial, immune cells. |
| GRP119: colon, ileum, pancreas, B-cells, islets of langerhans, stomach |
| TRPV1: Chondrocyt4es, brain neurons, epothelial cells, smooth muscles, mast, dendritic, lymphocytes, osteoclasts, hepatocytes, myotubes, fibroblasts, pancreatic B-cells. |
| 5HT Serotonin: cortex, hippocampus, nucleus accumbens, substantia nigra, ventral tegmental area, brain stem, PNS, enteric nervous system of GI, urinary tract |
| PPARa: duodenum, heart, kidney, liver, skeletal, adipose, adrenal gland, brain, intestines, kidney, liver , lung, skeletal, spleen. |
| Cannabis really affects everything! More research is needed. |
| Retrograde signaling (the Yin and Yang) | DSI depolarization induced suppression of inhibition aka pro-excitatory |
| Regulate neurotransmitter. | DSE depolarization induced suppression of Excitation aka pro-inhibitory |
| DSI inhibits GABA and promotes Glutamate: yang more energy |
| DSE inhibits Glutamate and promotes GABA: yin more rest and digest. |
| Endocannabinoid Deficiency and Excess | Deficiency: lower than normal endocannabinoid concentrations. Congenital, acquired through injury or chronic disease effect. Linked to migraine, fibromyalgia, IBS. |
| Excess: Overactive CB1 receptor signaling promotes obesity, insulin resistance, dyslipidemia, obesity and metabolic disorders. |
| def: sleep issues, mood, neurological dysfunction, pain intolerance |
| | excess- inflammatory state, excess GABA, fat storage, increase appetite, memory impairment, slow wound healing, BP issues |
| Phytocannabinoids | |
| THC | CB1 agonist |
| Induces DSE |
| Biphasic (too little or too much can cause different reaction) can be opposite of GABA; insomnia, heart palpitations, excited. |
| Positive Allosteric modulator to glycine receptors |
| | Psychoactive |
| CBD | Negative allosteric modulator CB1 |
| Negative allosteric modulator 5HT3 (nausea and moods in gastro system) |
| Agonist 5HT1A (moods like depression) |
| Positive Allosteric modulator to glycine receptors |
| | Psychoactive (still changes brain functions, perceived reality, moods, brain). |
| CBG | partial agonist CB2, (more in skeletal, joints). Increase GABA |
| Negative allosteric modulator CB1 |
| Induces DSE |
| | 5HT1A antagonist |
| CBN | Weak partial agonist CB1 and CB2 |
| | Product of THC degradation. Sedating. Less psychoactive, sleepy, sedated. |
| CBC | Weak partial agonist CB1 and CB2 |
| Agonist 5HT1A (help moods like depression and anxiety) |
| | FAAH inhibitors lead to increase AEA. Increase own endocannabinoids. |
| THCV (raw plant) | Agonist and Antagonist to CB1 Receptors |
| Biphasic (too little or too much can cause different reaction) can be opposite of GABA; insomnia, heart palpitations, excited. |
| Found in raw cannabis |
| | Great for overactive ECS |
| Terpenes the essential oils/hormones of the plant | |
| Pinene (upward) | smell: pine trees |
| Effect: mix of calming and energizing |
| Limonene (upward) | smell: citrus |
| effect: energizing mood and uplifting, mental clarity. |
| Mycene (descending) | woody/musky |
| effect: sedating, calming both shen and nerve type pain |
| Linalool (inward) | smell: floral |
| effect: calm shen and nerves |
| Trans/Beta-Caryophyilene (outward, cooling, expelling) | smell: spicy |
| | effect: anti-inflammatory, pain relief |
| Flavonoids | to utilize flavonoids , must eat or drink them |
| Cannaflavin A: antioxidant, anti-parasitic, anti-inflammatory, neuroprotection, binds with viral protein |
| Cannaflavin B; anti-cancer (pancreatic), Leishmaniasis |
| Cannaflavin C: anti-parasitic |
| | Diabetics benefit from Flavonoids. |
| THC | |
| Qi/nature | Hot/drying |
| Flavor | bitter, acrid |
| Organ affnity | Liver, Stomach, Heart |
| Directions | Ascending, descending, outward |
| Indications | Liver yang rising, blood stasis, qi stasis, shen disturbance |
| Trauma, pain, mood irregularities, menstrual irregularities, insomnia, anorexia, brain disorders |
| Cautions/contraindications | Yin xu, blood Xu |
| Paranoia, anxiety, palpitations, increased rate rate, somnolence, lethargy |
| Dosage | start 1-5mg. 2.5 to 5mg is effective. |
| CBD | |
| Qi/nature | cooling/moistening |
| Flavor | sweet, slight bitter |
| Organ affnity | Liv, Stomach, Heart |
| Directions | Descending, inward |
| Indications | Liver yang rising, internal wind, Liver yin def., Stomach Yin def. , shen disturbance |
| Tics, tremors, spasms, pain, insomnia, anorexia, mood irregularities |
| Cautions/contraindications | Caution in cold patients |
| too much can cause diarhea, drowsiness, decrease short term memory |
| Dosage | start 5-10mg, up to 10-40mg |
| THCV (raw plant) | |
| Qi/nature | Cool |
| Flavor | bitter, acrid |
| Organ affnity | Liv, Stomach, Spleen |
| Directions | ascending, outward |
| Indications | Stomach heat, spleen Qi xu, Liver heat, Liver qi stagnation, food stagnation |
| Excessive appetite, fatigue, foggy thinking |
| Cautions/contraindications | Yun xu |
| palpitations, ungrounded feeling. |
| Dosage | 5-7mg, low dose more effective |
| CBG | |
| Qi/nature | neutral, cool, drying |
| Flavor | bitter, acrid |
| Organ affnity | Large intestines, Stomach, kidneys, lung |
| Directions | Outward, descending |
| Indications | Moves Qi and blood, stops pain, drying |
| Bone and joint inflammation, assists bone matrix, Bi syndrome, intestinal inflammation, abdominal pain, anti-parasite/microbial |
| Cautions/contraindications | Blood xu |
| excess can cause dizziness, diarrhea, headaches, dry mouth |
| Dosage | 5-10mg. 10-40mg effective. |
| CBN | |
| Qi/nature | Neutral, warm, moistening |
| Flavor | bitter, sweet |
| Organ affnity | Liver, spleen, stomach |
| Directions | descending |
| Indications | Harmonize liver and stomach, nourish stomach, Liver yin def. |
| Anorexia, insomnia |
| Cautions/contraindications | Inconclusive, decrease in eosinophils in animal studies |
| Dosage | 15-40mg |
| CBC | |
| Qi/nature | Neutral, moistening |
| Flavor | bitter, sweet |
| Organ affnity | Liv, stomach, kidney |
| Directions | descending |
| Indications | Harmonize liver and stomach, nourish yin of liver and kidneys |
| Joint deformation, abdominal pain, nausea, osteoporosis, liver yang rising symptoms |
| Cautions/contraindications | inconclusive |
| Dosage | 5mg-25mg |
| Administration routes | |
| Inhalation | onset: 1-15 minutes |
| duration: 2-4 hours |
| Oral | onset: 30-180 min |
| duration: 5-8 hours |
| Oral/mucosal | onset: 15-20 minutes |
| duration: 4-6 hours |
| Transdermal (patch) | onset: 15-20 minutes |
| duration: 6-12 hours |
| Topical | onset: 20 minutes |
| duration: 2-3 hours |
| Rectal | onset: variable |
| | duration: variable |
| Certificate of Authenticity (COA) | Cannabis is a soil remediator and can absorb heavy metals |
| Minimize the possibility of contamination |
| Get a COA if possible unless you know the grower. |
| | Growing your own, use organic products. |
| other considerations | patients with lung disease should not smoke |
| Pediatrics, no THC |
| Not recommended in Pregnancy, crosses the placenta |
| Edibles enhance strength of THC |
| | patients with kidney disease, liver disease, IBD have slower absorption/excretion |
| Cannabis metabolism | THC and CBD affect psychiatric, cardiovascular drugs, immunotherapy. caution/contraindication |
| Cannabis in the clinic | common to see stagnation in middle jiao |
| can contribute to heart-kidney disharmony |
| may present with excess damp- swollen tongue, dark, pulse slippery |
| smoking high does: heat and phlegm |
| CUD: cannabis hyper-emesis syndrome |
| Cannabis hyperemesis Syndrome | abdominal pain, cramping, uncontrolled vomiting |
| (seen in chronic users) | symptoms relieved by hot showers |
| vomiting stops when they stop using |
| Cannabis Use Disorder (CUD) | large amounts of use over long period of time |
| unsuccessful attempts to cut down |
| too much time recovering from use |
| failing in school, work, and home to overuse. |
| social and interpersonal problems |
| psychological problems worsening from use |
| high tolerance, withdrawal symptoms stop after quitting. |
| Mood disorders, suicidal ideation, depressive symptoms. |
| | patients need to be monitored for mood disorders and pathological changes. |
| Neurological considerations | CB1 are highly concentrated in CNS and brain, affects neurology |
| THC has direct affinity to CB1 in areas of brain associated with mood, cognition, memory, motor coordination, hunger. |
| CBD affects neurology more indirectly. Interacts with serotonin, affects mood, reduces anxiety and depression. |
| Cannabis can potentiate the effects of antidepressant, anxiety and epileptic medication. Drowsiness, poor memory/concentration, dizziness, increaes paranoid. |
| Cannabis can increase mood disorders like anxiety, depression, mood, memory, and motivation. |
| Can lower motor skills, lower coordination. |
| Risk of schizophrenia in those with family history of psychosis. |
| | Reduced attention span, decreased cognitive and motor skills, ataxia, aphasia, unusual perceptions (hallucinations), anxiety. |
| Cardiovascular considerations | Cannabinoids can have a effect on blood pressure and heart rate |
| those with heart rate abnormalities (sick sinus syndrome) , supra ventricular tachycardia, Atrial fibrillation, advised not to exercise on THC until after 1-3 hours. |
| | interferes with cardiovascular medications, decreases platelets, increasing INR (clotting time), need to consult with doctor on cannabis use. |
| Oncology considerations | Cannabis can have anti-tumor effect but can also increase growth and spread. |
| Can worsen symptoms like tachycardia, respiratory distress, panic attacks, hypotension, syncope, mood/psychotic disorders. |
| Infection risk in immuno-compromised and hepatic damaged patients. |
| May increase tumor growth in HPV and neck squamous cell carcinoma, increase testicular tumor. |
| | Cannabis can interfere in CYP450 enzyme and interfere in immune system. |
| Pulmonary considerations | contaminants with smoking: cardon monoxide, ammonia, nitrosamines, tars are release and carcinogenic. |
| Decreased pulmonary function with inhaled cannabis causing cough, increased mucus, chest tightness, wheezing can exacerbate asthma, COPD, and lung illnesses. |
| Contaminant in poorly grown cannabis like mold, mildew, pesticides, heavy metals and irritate and worsen lungs. |
| | has a negative effect on the adaptive immunity of the lungs. More susceptible to infections. Immunocompromised should not smoke. |
| Gastrointestinal considerations | CHS- cannabis hyperemesis syndrome: vomiting, nausea |
| IBD treatment with cannabis has adverse effects: headache, dizziness, drowsiness, nausea. Helpful in Oncology nausea, but worse for gastrointestinal diseases. |
| CBD has been shown to increase hepatic injury and elevated transaminase in those with hepatic conditions. |
| CBD has potential to increase weight-loss, should be used with caution with those who are taking drugs that reduce mineral and nutrient absorption. |